Nemo Marjanovic

Nemo Marjanovic, an ARK Analyst specializing in genomics and AI in drug discovery, joins the conversation to illuminate how autonomous labs are revolutionizing research. He discusses the role of AI and robotics in making drug discovery more efficient and cost-effective. The conversation dives into blockchain's potential to decentralize research funding and tackle challenges in clinical trials. Finally, Nemo shares insights on the future of genomics and highlights innovative companies shaping this exciting field.